Israel’s CAPS Medical (see here previously) has received FDA Breakthrough Device Designation for its its PlasmaSure™ System to treat low- to intermediate-risk non-muscle invasive bladder cancer (NMIBC).

https://finance.yahoo.com/news/caps-medicals-plasmasure-receives-fda-110000164.html